NIH, FDA in Chaos as RFK Makes America "Healthy Again"

“He’s ventured far outside of his swim lane. It’s time to take him out of the pool,” Cantor Fitzgerald analysts write in a statement concerning the newly appointed DHSS secretary. Following the stepping down of FDA's Peter Marks, and a wave of uncertainty regarding federal staffing and research budgets throughout DHSS agencies, including the Food & Drug Administration and the National Institutes of Health, a widespread call for change has surfaced from the voices of countless American researchers and scientific leaders. Only a few hours ago, nearly 2,000 scientists signed a joint letter warning the White House of a newfound "climate of fear" among research institutions and an urgent call to halt policies that are negatively impacting the nation's research capacity.

Background

Robert F. Kennedy Jr., confirmed as Secretary of the Department of Health & Human Services (DHSS) in 2025 under President Trump, is a prominent Democratic figure known for his environmental advocacy and success in the Monsanto pesticide case. His efforts to protect New York's water and support indigenous lands have bolstered his reputation. Now focusing on human health, Kennedy launched the "Make America Healthy Again" campaign, prompting significant and widely-controversial changes in HHS, including FDA departures and NIH funding cuts, causing uncertainty in public health.

RFK Jr.'s Agenda

Controversies surrounding Robert F. Kennedy Jr.'s anti-vaccine stance have raised significant concerns about public trust in health systems. His previous claims have led him to consult Dr. Geier, a well-known anti-vaccine advocate, to support a study with the Centers for Disease Control. Kennedy's leadership has also prompted major restructuring within the HHS and NIH, resulting in a smaller division within these agencies. The recent resignation of Dr. Peter Marks from the FDA's CBER (Center for Biologics Evaluation and Research) underscores this shift, leading to numerous layoffs and budget cuts that raise alarms about diminished accountability and potential effects on public health.

Another key aspect of his agenda is addressing the use of artificial dyes in foods, particularly those marketed to children. While these dyes are generally recognized as safe (GRAS), some, like Red 40, have been linked to cancerous compounds in animal studies, though evidence in human studies remains absent. Kennedy has raised concerns about the FDA's lack of recent review of Red 40, questioning how such additives can remain in foods without thorough oversight. In response, spokespersons of Consumer Brand Association and founders of personal food brands have expressed gratitude for Kennedy's advocacy and pledged to enhance regulatory systems.

"Food is medicine, it treats our health" and the artificial dyes such as yellow 5 and blue 1, are linked to ADHD and cancers, according to RFK in his "Make America Healthy Again" tour. RFK exhorts states to take a stance to re-nourish and build up healthy generations of America.

Kennedy's latest agenda focuses on seed oils, arguing that substitution could help reduce obesity rates in America. While seed oils are rich in polyunsaturated fats that benefit cholesterol levels and blood sugar regulation, their excessive presence in ultra-processed foods is unnecessary. In one’s diet, it’s important to prioritize overall dietary balance rather than singling out specific ingredients like seed oils.

The larger push for transparency in public health underscores Kennedy's commitment to providing Americans with safer, cleaner food options. For parents, this serves as a reminder to weigh the convenience of ultra-processed snacks against their nutritional value, as these foods often contain additives that may pose health risks. However, this stands to contest with RFK Jr.'s latest actions as Secretary.

The recent dismissal of FDA tobacco director Brian King, under whose tenure teenage vaping has hit its lowest levels in the last decade, has raised further uncertainty. The juxtaposition between efforts to remove dyes with potential carcinogenic properties and the removal of officials who have significantly reduced teens' risk of lung cancer highlights an apparent contradiction, and is just one example of countless actions that don't match RFK Jr.'s promises.

In light of these shifts, it remains to be seen how Kennedy's drive to restructure the DHHS will shape the future of public health. With thousands of workers, including key policy makers and regulators, dismissed from their roles, Americans are left to consider: beyond trust, what safeguards remain to ensure scientific integrity in the face of such sweeping changes? Will the focus on individual consumer choices overshadow the systemic issues impacting public health, such as access to affordable healthcare and environmental pollution? How will the loss of experienced personnel affect the FDA's ability to regulate new drugs and medical devices, and the NIH's capacity to fund groundbreaking research? And ultimately, in a landscape where established scientific consensus is being challenged, who decides what constitutes "healthy," and what are the long-term consequences for the nation's well-being?

Further Reading:

If you liked this article:

Share this article with your network on LinkedIn with your thoughts or perspectives. Make sure to tag us @HealthcareInsights to join the conversation.
Subscribe to our free newsletter, HealthcareIn Quicktakes. You'll never miss an article, and will get access to exclusive reports.
Check out our library of articles and reports on biotech, healthcare, policy, and business.

Who We Are: At Healthcare Insights, we're covering the transformation of healthcare and bringing our readers the most pertinent takes on key issues in medicine, biotech, healthcare policy, and business. Our Spotlight Series ✦ features thoughts from the most influential figures in healthcare, including Nobel Prize-winning scientists shaping tomorrow's treatments and business leaders bringing new therapies to market. We strive to publish coverage that is authentic, impartial, and independent of any financial or political motive. For more information regarding our editorial standards, read our statement. If you'd like to contact the Editor, use this form to get in touch.

If you'd like to stay in the loop, make sure to subscribe to our free newsletter, HealthcareIn Quicktakes, and follow us @healthcareinsightsny across our social channels, including LinkedIn.

Legal Disclaimer:

The information provided in this article has been collected from various academic publications, industry reports/analyses, regulatory guidelines, media coverage, and legal analyses. The information provided is for general information purposes only and should not be construed for medical, legal, financial, or professional advice. Readers are advised to seek independent professional guidance where relevant. While we strive to ensure the accuracy and timeliness of our coverage, we claim no liability, representations, or warranties of any kind about the completeness, suitability, accuracy, reliability, authorship, or availability of this article and all pertaining data within this article. Neither the author nor the publication will assume liability for any loss or damage arising from the use of the information provided in the article. The information within this article may be outdated or inaccurate over time, and neither the author nor the publication are obligated to update or revise such information. We reserve the right to modify, remove, or substantially edit the article, including the disclaimer, at any time.